Literature DB >> 16479018

Kdo2-Lipid A of Escherichia coli, a defined endotoxin that activates macrophages via TLR-4.

Christian R H Raetz1, Teresa A Garrett, C Michael Reynolds, Walter A Shaw, Jeff D Moore, Dale C Smith, Anthony A Ribeiro, Robert C Murphy, Richard J Ulevitch, Colleen Fearns, Donna Reichart, Christopher K Glass, Chris Benner, Shankar Subramaniam, Richard Harkewicz, Rebecca C Bowers-Gentry, Matthew W Buczynski, Jennifer A Cooper, Raymond A Deems, Edward A Dennis.   

Abstract

The LIPID MAPS Consortium (www.lipidmaps.org) is developing comprehensive procedures for identifying all lipids of the macrophage, following activation by endotoxin. The goal is to quantify temporal and spatial changes in lipids that occur with cellular metabolism and to develop bioinformatic approaches that establish dynamic lipid networks. To achieve these aims, an endotoxin of the highest possible analytical specification is crucial. We now report a large-scale preparation of 3-deoxy-D-manno-octulosonic acid (Kdo)(2)-Lipid A, a nearly homogeneous Re lipopolysaccharide (LPS) sub-structure with endotoxin activity equal to LPS. Kdo(2)-Lipid A was extracted from 2 kg cell paste of a heptose-deficient Escherichia coli mutant. It was purified by chromatography on silica, DEAE-cellulose, and C18 reverse-phase resin. Structure and purity were evaluated by electrospray ionization/mass spectrometry, liquid chromatography/mass spectrometry and (1)H-NMR. Its bioactivity was compared with LPS in RAW 264.7 cells and bone marrow macrophages from wild-type and toll-like receptor 4 (TLR-4)-deficient mice. Cytokine and eicosanoid production, in conjunction with gene expression profiling, were employed as readouts. Kdo(2)-Lipid A is comparable to LPS by these criteria. Its activity is reduced by >10(3) in cells from TLR-4-deficient mice. The purity of Kdo(2)-Lipid A should facilitate structural analysis of complexes with receptors like TLR-4/MD2.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16479018     DOI: 10.1194/jlr.M600027-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  133 in total

1.  A mouse macrophage lipidome.

Authors:  Edward A Dennis; Raymond A Deems; Richard Harkewicz; Oswald Quehenberger; H Alex Brown; Stephen B Milne; David S Myers; Christopher K Glass; Gary Hardiman; Donna Reichart; Alfred H Merrill; M Cameron Sullards; Elaine Wang; Robert C Murphy; Christian R H Raetz; Teresa A Garrett; Ziqiang Guan; Andrea C Ryan; David W Russell; Jeffrey G McDonald; Bonne M Thompson; Walter A Shaw; Manish Sud; Yihua Zhao; Shakti Gupta; Mano R Maurya; Eoin Fahy; Shankar Subramaniam
Journal:  J Biol Chem       Date:  2010-10-05       Impact factor: 5.157

2.  SR-A, MARCO and TLRs differentially recognise selected surface proteins from Neisseria meningitidis: an example of fine specificity in microbial ligand recognition by innate immune receptors.

Authors:  Annette Plüddemann; Subhankar Mukhopadhyay; Marko Sankala; Silvana Savino; Mariagrazia Pizza; Rino Rappuoli; Karl Tryggvason; Siamon Gordon
Journal:  J Innate Immun       Date:  2008-09-11       Impact factor: 7.349

3.  Spinal glial TLR4-mediated nociception and production of prostaglandin E(2) and TNF.

Authors:  O Saito; C I Svensson; M W Buczynski; K Wegner; X-Y Hua; S Codeluppi; R H Schaloske; R A Deems; E A Dennis; T L Yaksh
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

4.  Density gradient enrichment of Escherichia coli conditional msbA mutants.

Authors:  William T Doerrler
Journal:  Appl Environ Microbiol       Date:  2007-10-26       Impact factor: 4.792

5.  Lipopolysaccharide stimulates platelet secretion and potentiates platelet aggregation via TLR4/MyD88 and the cGMP-dependent protein kinase pathway.

Authors:  Guoying Zhang; Jingyan Han; Emily J Welch; Richard D Ye; Tatyana A Voyno-Yasenetskaya; Asrar B Malik; Xiaoping Du; Zhenyu Li
Journal:  J Immunol       Date:  2009-06-15       Impact factor: 5.422

6.  Lipopolysaccharide inhibition of glucose production through the Toll-like receptor-4, myeloid differentiation factor 88, and nuclear factor kappa b pathway.

Authors:  Carl F Raetzsch; Natasha L Brooks; J McKee Alderman; Kelli S Moore; Peter A Hosick; Simon Klebanov; Shizuo Akira; James E Bear; Albert S Baldwin; Nigel Mackman; Terry P Combs
Journal:  Hepatology       Date:  2009-08       Impact factor: 17.425

7.  TLR-4 mediated group IVA phospholipase A(2) activation is phosphatidic acid phosphohydrolase 1 and protein kinase C dependent.

Authors:  Andrej Grkovich; Aaron Armando; Oswald Quehenberger; Edward A Dennis
Journal:  Biochim Biophys Acta       Date:  2009-02-20

8.  AIBP protects against metabolic abnormalities and atherosclerosis.

Authors:  Dina A Schneider; Soo-Ho Choi; Colin Agatisa-Boyle; Laurence Zhu; Jungsu Kim; Jennifer Pattison; Dorothy D Sears; Philip L S M Gordts; Longhou Fang; Yury I Miller
Journal:  J Lipid Res       Date:  2018-03-20       Impact factor: 5.922

9.  Interaction of lipopolysaccharide and phospholipid in mixed membranes: solid-state 31P-NMR spectroscopic and microscopic investigations.

Authors:  Kaoru Nomura; Takehiko Inaba; Kenichi Morigaki; Klaus Brandenburg; Ulrich Seydel; Shoichi Kusumoto
Journal:  Biophys J       Date:  2008-05-02       Impact factor: 4.033

10.  Lipidomics analysis of essential fatty acids in macrophages.

Authors:  Oswald Quehenberger; Aaron Armando; Darren Dumlao; Daren L Stephens; Edward A Dennis
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2008-11-08       Impact factor: 4.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.